Skip to content
Screener
Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$8.85M+18.1%-$9.19M-10.8%$1.54M+115%-$9.75M+3.5%-$10.81M-351%
$129K-20.9%$136K-17.6%$135K-21.5%$126K-34.7%$163K-10.4%
$2.83M-17.2%$2.62M+38.3%$2.47M+52.6%$2.2M+29.5%$3.42M+147%
-$5.28M-42.2%-$10.13M-38.4%-$6.48M-44.0%-$2.48M+56.5%-$3.71M+65.8%
$90K-58.3%$82K—$141K-81.3%$41K-18.0%$216K+27.8%
-$90K+48.9%-$82K—-$141K+80.3%-$41K+18.0%-$176K-4.1%
$134K+63.4%——$42.39M+338%$277K-90.7%$82K-98.6%
————$35.76M+699%————
-$5.37M-36.7%-$10.21M-41.3%-$6.62M-26.0%-$2.53M+56.1%-$3.93M+64.4%

FAQ

How much cash does TriSalus Life Sciences, Inc. generate?
TriSalus Life Sciences, Inc. (TLSI) generated -$24.4M in operating cash flow over the trailing twelve months.
What is TriSalus Life Sciences, Inc.'s free cash flow?
After $354.0K of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$24.7M over the trailing twelve months, down 11.6% year over year.
Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.